TargetMol

L 30

Product Code:
 
TAR-T24283
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24283-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24283-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24283-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
L 30 is a blocker of the sodium channel.
CAS:
21236-52-2
Formula:
C15H24N2O
Molecular Weight:
248.37
Purity:
0.98
SMILES:
CCN(CC)CCC(=O)Nc1c(C)cccc1C

References

1. Tangoh DA, Apinjoh TO, Mahmood Y, Nyingchu RV, Tangunyi BA, Nji EN, Azhar A, Achidi EA. Vitamin D Status and Its Associated Risk Factors among Adults in the Southwest Region of Cameroon. J Nutr Metab. 2018 Mar 19;2018:4742574. doi: 10.1155/2018/4742574. eCollection 2018. PubMed PMID: 29750125; PubMed Central PMCID: PMC5884209. 2. Li J, Wu DD, Zhang JX, Wang J, Ma JJ, Hu X, Dong WG. Mitochondrial pathway mediated by reactive oxygen species involvement in ?-hederin-induced apoptosis in hepatocellular carcinoma cells. World J Gastroenterol. 2018 May 7;24(17):1901-1910. doi: 10.3748/wjg.v24.i17.1901. PubMed PMID: 29740205; PubMed Central PMCID: PMC5937207. 3. Fukuyama T, Yamauchi S, Amagasa S, Hattori Y, Sasaki T, Nakajima H, Takei Y, Okuno J, Misawa Y, Fueki N, Kitamura M, Matsui H, Inaba Y, Hirabayashi S. Early prognostic factors for acute encephalopathy with reduced subcortical diffusion. Brain Dev. 2018 Apr 28. pii: S0387-7604(18)30148-7. doi: 10.1016/j.braindev.2018.04.005. [Epub ahead of print] PubMed PMID: 29716832. 4. Barber RL, Ekin AE, Sivakumar P, Howard K, O'Sullivan TA. Glucose Gel as a Potential Alternative Treatment to Infant Formula for Neonatal Hypoglycaemia in Australia. Int J Environ Res Public Health. 2018 Apr 27;15(5). pii: E876. doi: 10.3390/ijerph15050876. PubMed PMID: 29702618.